These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 11006251

  • 1. Methazolamide 1% in cyclodextrin solution lowers IOP in human ocular hypertension.
    Gudmundsdóttir E, Stefánsson E, Bjarnadóttir G, Sigurjónsdóttir JF, Gudmundsdóttir G, Masson M, Loftsson T.
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3552-4. PubMed ID: 11006251
    [Abstract] [Full Text] [Related]

  • 2. Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs.
    Gelatt KN, MacKay EO.
    Vet Ophthalmol; 2001 Mar; 4(1):61-7. PubMed ID: 11397321
    [Abstract] [Full Text] [Related]

  • 3. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G, Denis P, Chew P, Sharpe ED, Orengo-Nania S, Coote MA, Laganovska G, Volksone L, Zeyen T, Filatori I, James J, Aung T.
    J Glaucoma; 2009 Mar; 18(4):293-300. PubMed ID: 19365194
    [Abstract] [Full Text] [Related]

  • 4. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
    Maruyama K, Shirato S.
    J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
    [Abstract] [Full Text] [Related]

  • 5. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
    Hatanaka M, Grigera DE, Barbosa WL, Jordao M, Susanna R.
    J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
    [Abstract] [Full Text] [Related]

  • 6. Results of the European Glaucoma Prevention Study.
    Miglior S, Zeyen T, Pfeiffer N, Cunha-Vaz J, Torri V, Adamsons I, European Glaucoma Prevention Study (EGPS) Group.
    Ophthalmology; 2005 Mar; 112(3):366-75. PubMed ID: 15745761
    [Abstract] [Full Text] [Related]

  • 7. γ-Cyclodextrin nanoparticle eye drops with dorzolamide: effect on intraocular pressure in man.
    Gudmundsdottir BS, Petursdottir D, Asgrimsdottir GM, Gottfredsdottir MS, Hardarson SH, Jóhannesson G, Kurkov SV, Jansook P, Loftsson T, Stefánsson E.
    J Ocul Pharmacol Ther; 2014 Feb; 30(1):35-41. PubMed ID: 24205991
    [Abstract] [Full Text] [Related]

  • 8. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R, Queiroz CF, Santos LC, Avila MP, Magacho L.
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [Abstract] [Full Text] [Related]

  • 9. [Postoperative behavior of intraocular pressure after posterior Nd:YAG laser capsulotomy--critical evaluation in preventive administration of local carbonic anhydrase II inhibitor dorzolamide hydrochloride (Trusopt)].
    Lachmann C, Jörg KM, Trinkmann R.
    Klin Monbl Augenheilkd; 1998 Dec; 213(6):326-30. PubMed ID: 10048009
    [Abstract] [Full Text] [Related]

  • 10. Experience with Cosopt, the fixed combination of timolol and dorzolamide, after switch from free combination of timolol and dorzolamide, in Swiss ophthalmologists' offices.
    Gugleta K, Orgül S, Flammer J.
    Curr Med Res Opin; 2003 Dec; 19(4):330-5. PubMed ID: 12841926
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of glaucoma with carbonic anhydrase inhibitors in eyewash: medium term retrospective experience with dorzolamide].
    Detry-Morel M, De Hoste F.
    Bull Soc Belge Ophtalmol; 1997 Dec; 267():157-66. PubMed ID: 9745826
    [Abstract] [Full Text] [Related]

  • 12. Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension.
    Jansook P, Stefánsson E, Thorsteinsdóttir M, Sigurdsson BB, Kristjánsdóttir SS, Bas JF, Sigurdsson HH, Loftsson T.
    Eur J Pharm Biopharm; 2010 Oct; 76(2):208-14. PubMed ID: 20637867
    [Abstract] [Full Text] [Related]

  • 13. A randomized study of dorzolamide in the prevention of elevated intraocular pressure after anterior segment laser surgery. Dorzolamide Laser Study Group.
    Hartenbaum D, Wilson H, Maloney S, Vacarelli L, Orillac R, Sharpe E.
    J Glaucoma; 1999 Aug; 8(4):273-5. PubMed ID: 10464738
    [Abstract] [Full Text] [Related]

  • 14. Effects of ocular administration of ophthalmic 2% dorzolamide hydrochloride solution on aqueous humor flow rate and intraocular pressure in clinically normal cats.
    Rankin AJ, Crumley WR, Allbaugh RA.
    Am J Vet Res; 2012 Jul; 73(7):1074-8. PubMed ID: 22738060
    [Abstract] [Full Text] [Related]

  • 15. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor.
    Wilkerson M, Cyrlin M, Lippa EA, Esposito D, Deasy D, Panebianco D, Fazio R, Yablonski M, Shields MB.
    Arch Ophthalmol; 1993 Oct; 111(10):1343-50. PubMed ID: 8216014
    [Abstract] [Full Text] [Related]

  • 16. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C, Romanet JP, Nordmann JP, Allaire C, Groupe d'étude.
    J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
    [Abstract] [Full Text] [Related]

  • 17. Switching from systemic to the topical carbonic anhydrase inhibitor dorzolamide: effect on the quality of life of glaucoma patients with drug-related side effects.
    Nesher R, Ticho U.
    Isr Med Assoc J; 2003 Apr; 5(4):260-3. PubMed ID: 14509130
    [Abstract] [Full Text] [Related]

  • 18. [Decrease in intraocular pressure following administration of the local carbonic anhydrase inhibitor (MK-927)--comparison of the effect with pilocarpine].
    Pfeiffer N, Grehn F, Hennekes R, Garus H.
    Fortschr Ophthalmol; 1990 Apr; 87(2):128-30. PubMed ID: 2192972
    [Abstract] [Full Text] [Related]

  • 19. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
    Nixon DR, Yan DB, Chartrand JP, Piemontesi RL, Simonyi S, Hollander DA.
    Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.
    Shin DH, Feldman RM, Sheu WP, Fixed Combination Latanoprost/Timolol Study Group.
    Ophthalmology; 2004 Feb; 111(2):276-82. PubMed ID: 15019375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.